Breast Cancer Treatment and Pregnancy (PDQ®): Treatment - Patient Information [NCI] - Recurrent Breast Cancer
Recurrent breast cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the breast, in the chest wall, or in other parts of the body.
Breast Cancer Treatment and Pregnancy (PDQ®): Treatment - Patient Information [NCI] - Stages of Breast Cancer
After breast cancer has been diagnosed, tests are done to find out if cancer cells have spread within the breast or to other parts of the body. The process used to find out if the cancer has spread within the breast or to other parts of the body is called staging. The information gathered from the staging process determines the stage of the disease. It is important to know the stage in order to plan treatment.Methods used to stage breast cancer can be changed to make them safer for the fetus. Standard methods for giving imaging scans can be adjusted so that the fetus is exposed to less radiation. The following tests and procedures may be used in the staging process:Sentinel lymph node biopsy: The removal of the sentinel lymph node during surgery. The sentinel lymph node is the first lymph node to receive lymphatic drainage from a tumor. It is the first lymph node the cancer is likely to spread to from the tumor. A radioactive substance and/or blue dye is injected near the tumor. The
Appendix of Randomized Controlled Trials
Health Insurance Plan, United States 1963 [1,2]Age at entry: 40 to 64 years.Randomization: Individual, but with significant imbalances in the distribution of women between assigned arms, as evidenced by menopausal status (P < .0001) and education (P = .05). Sample size: 30,000 to 31,092 in study group and 30,565 to 30,765 in control group. Consistency of reports: Variation in sample size reports. Intervention: Annual two-view mammography (MMG) and CBE for 3 years. Control: Usual care. Compliance: Nonattenders to first screening (35% of the screened population) were not reinvited.Contamination: Screening MMG was not available outside the trial, but frequency of CBE performance among control women is unknown.Cause of death attribution: Women who died of breast cancer that had been diagnosed before entry into the study were excluded from the comparison between the screening and control groups. However, these exclusions were determined differently
Breast Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Risks of Breast Cancer Screening
Screening tests have risks.Decisions about screening tests can be difficult. Not all screening tests are helpful and most have risks. Before having any screening test, you may want to discuss the test with your doctor. It is important to know the risks of the test and whether it has been proven to reduce the risk of dying from cancer.The risks of breast cancer screening tests include the following: Finding breast cancer may not improve health or help a woman live longer. Screening may not help you if you have fast-growing breast cancer or if it has already spread to other places in your body. Also, some breast cancers found on a screening mammogram may never cause symptoms or become life-threatening. When such cancers are found, treatment would not help you live longer and may instead cause serious side effects. At this time, it is not possible to be sure which breast cancers found by screening will cause problems and which ones will not.False-negative test results can occur.
Male Breast Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Treatment Options for Male Breast Cancer
Initial Surgical ManagementPrimary standard treatment is a modified radical mastectomy with axillary dissection.[1,2,3] Responses are generally similar to those seen in women with breast cancer. Breast conservation surgery with lumpectomy and radiation therapy has also been used and results have been similar to those seen in women with breast cancer. (Refer to the PDQ summary on Breast Cancer Treatment for more information.)Adjuvant TherapyIn men with node-negative tumors, adjuvant therapy should be considered on the same basis as for a woman with breast cancer since there is no evidence that response to therapy is different for men or women.In men with node-positive tumors, both chemotherapy plus tamoxifen and other hormonal therapy have been used and can increase survival to the same extent as in women with breast cancer. Currently, no controlled studies have compared adjuvant treatment options. Approximately 85% of all male breast cancers are estrogen
Breast Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Changes to This Summary (05 / 31 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Changes were made to this summary to match those made to the health professional version.
Breast Cancer Treatment and Pregnancy (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Breast Cancer Treatment and Pregnancy
Breast cancer is the most common cancer in pregnant and postpartum women,occurring in about 1 in 3,000 pregnant women. The average patient is between 32 to 38 years of age and,with many women choosing to delay childbearing,it is likely that the incidence of breast cancer during pregnancy will increase. Breast cancer pathology is similar in age-matched pregnant and nonpregnant women. Hormone ...
Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Breast Cancer
Breast cancer is a disease in which malignant (cancer) cells form in the tissues of the breast. The breast is made up of lobes and ducts. Each breast has 15 to 20 sections called lobes,which have many smaller sections called lobules. Lobules end in dozens of tiny bulbs that can produce milk. The lobes,lobules,and bulbs are linked by thin tubes called ducts. Anatomy of the breast,showing ...
Male Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Locally Recurrent Male Breast Cancer
For men with locally recurrent disease (cancer that has come back in a limited area after treatment), treatment is usually either:Surgery combined with chemotherapy; orRadiation therapy combined with chemotherapy.
Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - To Learn More About Breast Cancer
For more information from the National Cancer Institute about breast cancer, see the following: Breast Cancer Home PageWhat You Need to Know About™ Breast CancerSurgery Choices for Women with DCIS or Breast CancerPreventive MastectomyBreast Reconstruction After MastectomyAdjuvant and Neoadjuvant Therapy for Breast CancerSentinel Lymph Node BiopsyDrugs Approved for Breast CancerHormone Therapy for Breast CancerUnderstanding Cancer Series: Targeted Therapies (Advances in Targeted Therapies and Targeted Therapies for Breast Cancer)Targeted Cancer TherapiesInflammatory Breast CancerBRCA1 and BRCA2: Cancer Risk and Genetic TestingGenetic Testing for Hereditary Cancer SyndromesFor general cancer information and other resources from the National Cancer Institute, see the following:What You Need to Know About™ CancerUnderstanding Cancer Series: CancerCancer StagingChemotherapy and You: Support for People With CancerRadiation Therapy and You: Support for People With CancerCoping with